Safety and Efficacy Study of Albiglutide in Type 2 Diabetes

NCT00849017 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
309
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

GlaxoSmithKline